Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI7352 in painful diabetic neuropathy
NCT03755934Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Nov 2018
- Primary completion
- Jun 2023
- Modality
- Bispecific Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of MEDI7352 in diabetic neuropathy, sponsored by AstraZeneca. Started Nov 2018; status: terminated.
02
Drugs
MEDI7352
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT03755934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03755934.